Document is current
Any future updates will be listed below
-
Authors
Javor, Josh https://orcid.org/0000-0002-9556-0021
Ewoldt, Jourdan K.
Cloonan, Paige E.
Chopra, Anant
Luu, Rebeccah J.
Freychet, Guillaume https://orcid.org/0000-0001-8406-798X
Zhernenkov, Mikhail https://orcid.org/0000-0003-3604-0672
Ludwig, Karl
Seidman, Jonathan G.
Seidman, Christine E.
Chen, Christopher S.
Bishop, David J.
-
Funding
Funding for this research was provided by:
National Science Foundation (1647837)
National Science Foundation (1647837)
National Science Foundation (1647837)
National Science Foundation (1647837)
National Science Foundation (1647837)
National Science Foundation (1647837)
National Science Foundation (1647837)
National Science Foundation (1647837)
U.S. Department of Energy (DESC0012704)
U.S. Department of Energy (DESC0012704)
- License Information
-
More Information
Article History
Received: 28 August 2020
Revised: 13 November 2020
Accepted: 3 December 2020
First Online: 27 January 2021
Conflict of interest
: Drs. C.E. Seidman and J.G. Seidman are founders and own shares in MyoKardia Inc, a startup company that is developing therapeutics that target the sarcomere. MyoKardia had no role in performing or approving these studies. The other authors report no conflicts.
